Vaccine hesitancy and acceptance: an examination of predictive factors in COVID-19 vaccination in Saudi Arabia.

Fahmi Hassan Fadhel
Author Information
  1. Fahmi Hassan Fadhel: Psychology Department, College of Education - King Khalid University- Saudi Arabia, Abha. Areej Street, Building No. 7273, Flat 1P. O. Box: 4113, Abha 61421, Kingdom of Saudi Arabia. ORCID

Abstract

Vaccine hesitancy is a global health issue and can be affected by several variables. We explored the predictive factors and causes of vaccine hesitancy among adults in Saudi Arabia. An online survey method with multiple regression analysis was used to identify factors predicting of vaccine hesitancy in 558 adults (46.24% women and 53.76% men). The prevalence of vaccine hesitancy is 20.6%, with higher rates among females, young people and single people. About 70% of the participants believe that vaccine hesitancy is due to concerns about the safety and efficacy of the vaccine, a lack of information about the disease and vaccine or social media. The vaccine acceptance rate is 71.3%; 17.2% are not willing to accept a COVID-19 vaccine and 11.5% are unsure. Males and married people are more accepting of the vaccine. The risk factors that predict vaccine hesitancy include age, gender, belief in conspiracy theories and psychosocial factors. Meanwhile, age, gender, belief in conspiracy theories, concerns about the safety and efficacy of the vaccine and psychosocial factors significantly predict vaccine acceptance. The high rate of vaccine hesitancy could undermine efforts to combat COVID-19. Factors predicting vaccine hesitancy can be used in interventions to address this issue during major epidemics.

Keywords

References

  1. Vaccines (Basel). 2021 Jan 07;9(1): [PMID: 33430428]
  2. Hum Vaccin Immunother. 2021 Aug 3;17(8):2639-2646 [PMID: 33769209]
  3. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  4. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  5. Vaccine. 2015 Aug 14;33(34):4165-75 [PMID: 25896384]
  6. Front Public Health. 2021 Apr 21;9:626852 [PMID: 33968880]
  7. Health Promot Int. 2022 Apr 29;37(2): [PMID: 34510187]
  8. BMC Public Health. 2021 Jun 12;21(1):1129 [PMID: 34118897]
  9. Eur J Epidemiol. 2020 Aug;35(8):785-788 [PMID: 32808095]
  10. Vaccines (Basel). 2019 Oct 18;7(4): [PMID: 31635270]
  11. Rev Saude Publica. 2021 Apr 23;55:12 [PMID: 33909868]
  12. Health Promot Int. 2022 Feb 17;37(1): [PMID: 34244738]
  13. Vaccine. 2019 Feb 4;37(6):848-856 [PMID: 30642731]
  14. Health Promot Int. 2022 Feb 17;37(1): [PMID: 34171926]
  15. Brain Behav Immun. 2021 May;94:41-50 [PMID: 33713824]
  16. Ann Intern Med. 2020 Dec 15;173(12):964-973 [PMID: 32886525]
  17. BMJ. 2019 Jul 3;366:l4457 [PMID: 31270071]
  18. Health Commun. 2020 Dec;35(14):1718-1722 [PMID: 33124475]
  19. Health Promot Int. 2021 Apr 15;36(2):524-534 [PMID: 33450022]
  20. Vaccines (Basel). 2020 Dec 30;9(1): [PMID: 33396832]
  21. Int Immunopharmacol. 2021 Aug;97:107724 [PMID: 33951558]
  22. EClinicalMedicine. 2020 Sep;26:100495 [PMID: 32838242]
  23. Lancet. 2021 Mar 27;397(10280):1165-1167 [PMID: 33639088]
  24. Papillomavirus Res. 2016 Dec;2:167-172 [PMID: 29074176]
  25. Vaccine. 2021 Apr 8;39(15):2024-2034 [PMID: 33722411]
  26. Paediatr Drugs. 2020 Apr;22(2):105-111 [PMID: 32072472]
  27. BMJ Glob Health. 2020 Oct;5(10): [PMID: 33097547]
  28. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  29. Vaccines (Basel). 2020 Aug 27;8(3): [PMID: 32867224]
  30. Health Promot Int. 2022 Feb 17;37(1): [PMID: 33993249]
  31. PLoS One. 2014 Feb 20;9(2):e89177 [PMID: 24586574]
  32. Int J Environ Res Public Health. 2021 May 02;18(9): [PMID: 34063327]
  33. Vaccine. 2018 Jan 29;36(5):660-667 [PMID: 29289384]
  34. Vaccine. 2014 Apr 17;32(19):2150-9 [PMID: 24598724]
  35. J Affect Disord. 2021 Sep 1;292:552-558 [PMID: 34147967]
  36. Infect Drug Resist. 2021 Jun 24;14:2361-2367 [PMID: 34194232]
  37. PLoS Med. 2021 Nov 5;18(11):e1003823 [PMID: 34739480]
  38. Health Psychol. 2018 Apr;37(4):307-315 [PMID: 29389158]
  39. Front Microbiol. 2020 Mar 17;11:372 [PMID: 32256465]
  40. Perspect Psychol Sci. 2021 Mar;16(2):191-203 [PMID: 33501900]

MeSH Term

Adult
Male
Female
Humans
Adolescent
COVID-19 Vaccines
Saudi Arabia
Vaccination Hesitancy
COVID-19
Vaccination

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinehesitancyfactorsCOVID-19peopleacceptancepredictconspiracyVaccineissuecanpredictiveamongadultsSaudiArabiausedpredictingconcernssafetyefficacyrateagegenderbelieftheoriespsychosocialglobalhealthaffectedseveralvariablesexploredcausesonlinesurveymethodmultipleregressionanalysisidentify5584624%women5376%menprevalence206%higherratesfemalesyoungsingle70%participantsbelieveduelackinformationdiseasesocialmedia713%172%willingaccept115%unsureMalesmarriedacceptingriskincludeMeanwhilesignificantlyhighundermineeffortscombatFactorsinterventionsaddressmajorepidemicsacceptance:examinationvaccinationtheory

Similar Articles

Cited By